Comparing Mechanisms: GLP-1 vs Dual Hormone Action
What Is Better Wegovy or Mounjaro for Switching Patients?
When deciding what is better Wegovy or Mounjaro for patients considering a switch, the choice often depends on individual response and circumstances rather than one being universally superior. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors, offering a dual mechanism approach to weight management.
Patients typically switch between these medications due to side effects, availability concerns, cost considerations, or simply seeking an alternative approach after reaching a plateau. At EverydayMeds (GPhC #9012878), we understand that switching GLP-1 medications requires careful planning and professional guidance. Your prescriber will assess your current dose, response, and medical history to determine the most appropriate transition strategy, ensuring continuity of care while optimising your weight management journey.
Wegovy vs Mounjaro Pricing: Switch & Save Opportunities
Cost comparison plays a crucial role when determining what is better Wegovy or Mounjaro for budget-conscious patients. EverydayMeds offers competitive Wegovy pricing starting at £79.99 for the 0.25mg starter dose with code FIRST40 for new customers, while returning patients can use code DOSE25. Our pricing structure includes single pens and convenient bundles: the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) is priced at £369.99 for patients requiring steady progression.
The financial advantage of switching often becomes apparent during maintenance therapy, where our Consistency bundles provide extended supply security. For patients reaching the 2.4mg maintenance dose, our Ultimate Stability Trio offers three months of treatment for £649.99. These competitive prices, combined with our discount codes applied at checkout, can represent significant savings compared to alternative pharmacy options, making the switch both clinically and financially beneficial.
Clinical Evidence: What Is Better Wegovy or Mounjaro Based on Trials?
Understanding what is better Wegovy or Mounjaro requires examining the clinical evidence, though direct head-to-head comparisons are limited due to different trial designs and patient populations. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in STEP 1, with sustained results of 15.2% at two years in STEP 5 (Wilding et al., NEJM, 2021). The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events among patients using Wegovy.
Mounjaro's SURMOUNT trials showed different efficacy patterns due to its dual hormone mechanism, though comparing these results directly would be inappropriate given varying trial methodologies. Both medications are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber will consider your individual medical history, current response, and treatment goals when determining which option may be more suitable for your circumstances.
How Wegovy Works: GLP-1 Mechanism for Switching Patients
For patients wondering what is better Wegovy or Mounjaro, understanding Wegovy's mechanism helps inform the decision. Wegovy works as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. When injected once weekly, semaglutide activates GLP-1 receptors in your brain's appetite centres, reducing hunger signals and increasing feelings of fullness after smaller meals. This mechanism may also help reduce food cravings, particularly for high-calorie, palatable foods. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. Unlike Mounjaro's dual receptor approach, Wegovy's selective GLP-1 action provides a focused mechanism that many patients find effective and well-tolerated.
EverydayMeds Ordering Process: Seamless Switching Experience
Switching between GLP-1 medications through EverydayMeds ensures continuity of care with our streamlined process designed for treatment transitions. Our 3-minute online clinical assessment captures your current medication history, previous responses, and switching rationale to provide your prescriber with comprehensive information. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent switches where treatment continuity is critical. Once approved, your new Wegovy prescription is dispatched via next-day delivery using our temperature-controlled cold-chain system. Our GPhC-registered pharmacy (#9012878) maintains detailed records of your treatment history, ensuring your prescriber can make informed decisions about dose equivalencies and transition protocols when switching from other GLP-1 medications.
Storage Advantages: What Is Better Wegovy or Mounjaro for Lifestyle Flexibility
A practical consideration when evaluating what is better Wegovy or Mounjaro involves storage requirements and travel flexibility. Wegovy offers superior storage convenience, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves particularly valuable for business travellers, holidaymakers, or patients with inconsistent access to refrigeration. Both medications require refrigerated storage (2-8°C) before first use, and both utilise pre-filled injection pens for convenience. Wegovy's FlexTouch pen system provides dose confirmation and is designed for once-weekly administration, following a structured escalation schedule from 0.25mg through to the 2.4mg maintenance dose. The extended room temperature stability makes Wegovy an attractive option for patients prioritising lifestyle flexibility during their weight management journey.
Dose Conversion Guidance: What Is Better Wegovy or Mounjaro When Switching
Determining what is better Wegovy or Mounjaro often involves understanding dose conversion principles when switching between these prescription-only medicines. While no official conversion guidelines exist due to different mechanisms of action, prescribers typically consider your current response, tolerance, and treatment duration when planning the transition. Patients switching to Wegovy usually restart the standard escalation protocol beginning with 0.25mg weekly, regardless of their previous medication dose, to optimise tolerance and minimise side effects.
This restart approach, while initially seeming like a step backward, allows proper adjustment to Wegovy's selective GLP-1 mechanism and reduces the risk of gastrointestinal side effects common during treatment initiation. Your prescriber may adjust this standard approach based on your individual circumstances, previous response patterns, and medical history. EverydayMeds stocks all Wegovy doses to support this escalation journey, from starter doses through to maintenance therapy, ensuring uninterrupted treatment supply during your switching process.
EverydayMeds Switch & Save Programme: Exclusive Benefits
Our Switch & Save programme addresses the question of what is better Wegovy or Mounjaro by removing financial and logistical barriers to treatment transitions. New customers switching to Wegovy receive immediate access to our FIRST40 discount code, while existing customers benefit from the DOSE25 code for continued savings. Beyond pricing advantages, our programme includes priority prescriber review for switching patients, ensuring minimal treatment interruption during the transition period. We maintain detailed treatment histories enabling informed discussions between you and your prescriber about optimal switching strategies.
The programme extends to our bundle offerings, where patients can secure multiple doses for smooth escalation or maintain consistent supply during the critical early months post-switch. Our clinical team provides ongoing support through the transition, monitoring for any concerns and ensuring your switch to Wegovy proceeds smoothly. This comprehensive approach makes EverydayMeds the logical choice for patients ready to explore whether Wegovy represents a better option for their individual weight management needs.
Start your Wegovy switch assessment today with codes FIRST40 or DOSE25 applied at checkout. Our experienced prescribers will evaluate whether switching represents the right decision for your weight management journey, considering your medical history, current treatment response, and individual circumstances. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy, ensuring you have access to expert guidance regardless of which medication proves most suitable. Take the first step towards optimising your weight management treatment with EverydayMeds' comprehensive switching support. Remember that weight management is a long-term commitment requiring ongoing professional supervision alongside lifestyle modifications for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
